The Journal of Pediatrics
Volume 150, Issue 1 , Pages 7-11 , January 2007

Recombinant Human Insulin-Like Growth Factor I (rhIGF-I) and rhIGF-I/rhIGF-Binding-Protein-3: New Growth Treatment Options?

  • Arlan L. Rosenbloom, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Dr Arlan L. Rosenbloom, Children’s Medical Services Center, 1701 Southwest 16th Avenue, Gainesville, FL 32608.

Received 13 May 2006 ,Revised 23 August 2006 ,Accepted 30 September 2006.

References 

  1. Rosenbloom AL. Physiology and disorders of the growth hormone receptor and growth hormone signal transduction. Endocrine. 2000;12:107–109
  2. Domene HM, Bengolea SV, Jasper HG, Boisclair YR. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest. 2005;28(5 suppl):43–46
  3. Collett-Solberg P, Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine. 2000;12:121–136
  4. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996;335:1363–1367
  5. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab. 2005;90:2855–2864
  6. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, et al. Intrauterine Growth Retardation (IUGR) Study Group IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med. 2003;349:2211–2222
  7. Kawashima Y, Kanzaki S, Yang F, Kinoshita T, Hanaki K, Nagaishi J, et al. Mutation cleavage of insulin-like growth factor receptor in a short stature child born with intrauterine growth retardation. J Clin Endocrinol Metab. 2005;90:4679–4687
  8. Geffner ME. The growth without growth hormone syndrome. Endocrinol Metab Clin North Am. 1996;25:649–663
  9. Guevara-Aguirre J, Vasconez O, Martinez V, Martinez AL, Rosenbloom AL, Diamond FB, et al. A randomized double-blind, placebo-controlled trial of safety and efficacy of recombinant insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab. 1995;80:1393–1398
  10. Rosenbloom AL. IGF-I treatment of diabetes. Pediatric Diabetes. 2001;2:123–130
  11. Genentech discontinues IGF-I drug development effort in diabetes. September 5, 1997. Available online at: http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=4842. Accessed June 30, 2006.
  12. Kemp SE, Thrailkill KM. SomatoKine: is there a use in treating growth disorders?. Curr Opin Investig Drugs. 2005;6:373–377
  13. Guevara-Aguirre J, Frane J, Bright G. A comparison of four IGF-I assay systems for the detection of biochemical IGF-I deficiency. Presented at the seventh joint meeting of the European Society for Pediatric Endocrinology and the Lawson Wilkins Pediatric Endocrinology Society; September 21-24, 2005; Lyon France. Abstract #139275.
  14. Khosravi J, Diamandi A, Bodani U, Khaja N, Krishna RG. Pitfalls of immunoassay and sample for IGF-I: comparison of different assay methodologies using various fresh and stored serum samples. Clin Biochem. 2005;38:659–666
  15. Katz LEL, DeLeón DD, Zhao H, Jawad AF. Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1. J Clin Endocrinol Metab. 2002;87:2978–2983
  16. Wudy SA, Hagemann S, Dempfle A, Ringler G, Blum WF, Berthold LD, et al. Children with idiopathic short stature are poor eaters and have decreased body mass index. Pediatrics. 2005;116:e52–e57
  17. Klinger B, Laron Z. Three year IGF-I treatment of children with Laron syndrome. Pediatr Endocrinol Metab. 1995;8:149–158
  18. Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Rosenfeld RG. Two year treatment of GH receptor deficiency (GHRD) with recombinant insulin-like growth factor-I in 22 children: comparison of two dosage levels and to GH treated GH deficiency. J Clin Endocrinol Metab. 1997;82:629–633
  19. Backeljauw PW, Chernausek SD. Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans. Horm Res. 2006;65(suppl 1):21–27
  20. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Wilton P The Working Group on Growth Hormone Insensitivity Syndromes. Long-term treatment of growth hormone insensitivity syndrome with IGF-I (Results of the European Multicentre Study). Horm Res. 1999;51:128–134
  21. van der Eerden , Karperien M, Wit JM. Systemic and local regulation of the growth plate. Endocr Rev. 2003;24:782–801
  22. Ohlsson C, Jansson J-O, Isaksson O. Effects of growth hormone and insulin-like growth factor 1 on body growth and adult bone metabolism. Curr Opin Rheumatol. 2000;12:346–348
  23. MacGillivray MH, Baptista J, Johanson A Genentech Study Group. Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. J Clin Endocrinol Metab. 1996;81:1806–1809
  24. Guevara-Aguirre J, Guevara-Aguirre M, Rosenbloom AL. Absence of hypoglycemia in response to varying doses of recombinant human insulin-like growth factor-I (rhIGF-I) in children and adolescents with low serum concentrations of IGF-I. Acta Pædiatrica. 2006;95:199–200
  25. Krzisnik C, Battelino T. Five year treatment with IGF-I of a patient with Laron syndrome in Slovenia (a follow-up report). J Pediatr Endocrinol Metab. 1997;10:443–447
  26. Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol. 1998;48:81–87
  27. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, et al. Growth hormone insensitivity (GHI) associated with a STAT-5b mutation. N Engl J Med. 2003;349:1139–1147
  28. Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, Ocal G, et al. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab. 2005;90:4260–4266
  29. Rosenbloom AL. Is there a role for recombinant insulin-like growth factor-I (rhIGF-I) in the treatment of idiopathic short stature?. Lancet. 2006;368:612–616
  30. Osio D, Dahlgren J, Albertsson-Wikland K, Westphal O. Improved final height with long-term growth hormone treatment in Noonan syndrome. Acta Paediatrica. 2005;94:1232–1237
  31. Limal J-M, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, et al. Noonan syndrome: relationships between genotype, growth, and growth factors. J. Clin Endocrinol Metab. 2006;91:300–306
  32. Rosenfeld RG. The IGF system: new developments relevant to pediatric practice. Endocr Dev. 2005;9:1–10
  33. Clayton PE, Ayoola O, Whatmore AJ. Patient selection for IGF-I therapy. Horm Res. 2006;65(suppl 1):28–34
  34. Park P, Cohen P. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS). Growth Hormone IGF Res. 2005;15:S13–S32
  35. Domene HM, Bengolea SV, Martinez AS, Ropelato MG, Pennisi P, Scaglia P, et al. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Engl J Med. 2004;350:570–577
  36. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG. Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology. 1996;137:1913–1920
  37. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest. 1993;91:391–396
  38. Camacho-Hübner C, Storr HI, Miraki-Moud F, Rose S, Preece MA, Sleevi M, et al. Pharmacokinetic studies of rhIGF-I/rhIGFBP-3 complex administered to patients with growth hormone insensitivity syndrome (GHIS). Presented at the 85th Annual Meeting of the Endocrine Society, June 2003; Philadelphia, PA. Abstract P2-356.

PII: S0022-3476(06)00929-2

doi: 10.1016/j.jpeds.2006.09.040

The Journal of Pediatrics
Volume 150, Issue 1 , Pages 7-11 , January 2007

Article Tools